0001493152-23-000014.txt : 20230103
0001493152-23-000014.hdr.sgml : 20230103
20230103061018
ACCESSION NUMBER: 0001493152-23-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rich Tyvin
CENTRAL INDEX KEY: 0001945208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41488
FILM NUMBER: 23500079
MAIL ADDRESS:
STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
STREET 2: ONE RESEARCH COURT, SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc.
CENTRAL INDEX KEY: 0001757499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 2404034212
MAIL ADDRESS:
STREET 1: ONE RESEARCH COURT
STREET 2: SUITE 450
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
ownership.xml
X0306
4
2022-12-29
0
0001757499
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
0001945208
Rich Tyvin
C/O SHUTTLE PHARMACEUTICALS HOLDINGS
ONE RESEARCH COURT, SUITE 450
ROCKVILLE
MD
20850
0
1
0
0
Chief Medical Officer
COMMON STOCK
2022-12-29
4
S
0
1414
1.605
D
2429
D
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 3,843 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
Consists of 2,429 shares of SHPH common stock.
/s/ Tyvin Rich
2023-01-03